Fornstedt, B., Pileblad, E
Examples from Health Canada's April 2026 warning about peptides
Some providers allow patients who previously tolerated high-dose tirzepatide to advance through these early semaglutide doses more quickly, moving from 0.25 to 0.5 milligrams after two weeks instead of four
Providers may choose to customize a person's dose of compounded semaglutide for weight loss based on their medical history, side effects, or weight loss goals
Hormone-based approaches work with it, addressing the root signals that drive appetite rather than asking for conscious restraint against them
GLP-1 medications for weight management are contraindicated in pregnancy, and those for diabetes should generally be discontinued before planned pregnancy